111 related articles for article (PubMed ID: 3708036)
1. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders.
Sora I; Nishimon K; Otsuki S
Biol Psychiatry; 1986 Jun; 21(7):621-31. PubMed ID: 3708036
[TBL] [Abstract][Full Text] [Related]
2. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
Rybakowski J; Plocka M
J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
[TBL] [Abstract][Full Text] [Related]
3. The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.
Hubain PP; Simonnet MP; Mendlewicz J
Neuropsychobiology; 1986; 16(2-3):57-60. PubMed ID: 3587576
[TBL] [Abstract][Full Text] [Related]
4. Cortisol response to dexamethasone and noradrenergic function in depression.
Maes M; de Ruyter M; Suy E
Acta Psychiatr Scand; 1987 Feb; 75(2):171-5. PubMed ID: 3565061
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic function and the dexamethasone suppression test in depression.
Morinobu S; Satoh H; Endoh M; Totsuka S
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and behavioural responses to methylphenidate in depression.
Joyce PR; Donald RA; Nicholls MG; Livesey JH; Abbott RM
Psychol Med; 1986 Aug; 16(3):531-40. PubMed ID: 3763771
[TBL] [Abstract][Full Text] [Related]
7. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
Clower CG
J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
[TBL] [Abstract][Full Text] [Related]
8. Depression, negative and positive symptoms, and the DST in schizophrenia.
Minas IH; Jackson HJ; Joshua SD; Burgess PM
Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
[TBL] [Abstract][Full Text] [Related]
9. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
[TBL] [Abstract][Full Text] [Related]
10. The dexamethasone suppression test in residual schizophrenia with depression.
Munro JG; Hardiker TM; Leonard DP
Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
Zhou DF; Shen YC; Shu LN; Lo HC
Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
[TBL] [Abstract][Full Text] [Related]
12. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
Rybakowski J; Linka M; Matkowski K; Kanarkowski R
Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
[TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
Mück-Seler D; Pivac N; Jakovljević M; Brzović Z
Biol Psychiatry; 1999 Jun; 45(11):1433-9. PubMed ID: 10356625
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone suppression test: use of two different dexamethasone doses.
Hwang S; Zander J; Garvey M
J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
[TBL] [Abstract][Full Text] [Related]
15. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
[TBL] [Abstract][Full Text] [Related]
16. The effect of diagnosis and age on the DST: a metaanalytic approach.
Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
[TBL] [Abstract][Full Text] [Related]
17. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
Maj M; Ariano MG; Arena F; Kemali D
Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030
[TBL] [Abstract][Full Text] [Related]
18. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
[TBL] [Abstract][Full Text] [Related]
19. Positive relationship between the catecholaminergic turnover and the DST results in depression.
Maes M; Vandewoude M; Schotte C; Martin M; Blockx P
Psychol Med; 1990 Aug; 20(3):493-9. PubMed ID: 2173010
[TBL] [Abstract][Full Text] [Related]
20. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
Doran AR; Rubinow DR; Roy A; Pickar D
Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
